83 related articles for article (PubMed ID: 15231692)
1. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo.
Trapasso F; Yendamuri S; Dumon KR; Iuliano R; Cesari R; Feig B; Seto R; Infante L; Ishii H; Vecchione A; During MJ; Croce CM; Fusco A
Carcinogenesis; 2004 Nov; 25(11):2107-14. PubMed ID: 15231692
[TBL] [Abstract][Full Text] [Related]
2. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
[TBL] [Abstract][Full Text] [Related]
3. Thyroid cell transformation inhibits the expression of a novel rat protein tyrosine phosphatase.
Zhang L; Martelli ML; Battaglia C; Trapasso F; Tramontano D; Viglietto G; Porcellini A; Santoro M; Fusco A
Exp Cell Res; 1997 Aug; 235(1):62-70. PubMed ID: 9281353
[TBL] [Abstract][Full Text] [Related]
4. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).
Trapasso F; Iuliano R; Boccia A; Stella A; Visconti R; Bruni P; Baldassarre G; Santoro M; Viglietto G; Fusco A
Mol Cell Biol; 2000 Dec; 20(24):9236-46. PubMed ID: 11094075
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
Iuliano R; Le Pera I; Cristofaro C; Baudi F; Arturi F; Pallante P; Martelli ML; Trapasso F; Chiariotti L; Fusco A
Oncogene; 2004 Nov; 23(52):8432-8. PubMed ID: 15378013
[TBL] [Abstract][Full Text] [Related]
6. The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.
Keane MM; Lowrey GA; Ettenberg SA; Dayton MA; Lipkowitz S
Cancer Res; 1996 Sep; 56(18):4236-43. PubMed ID: 8797598
[TBL] [Abstract][Full Text] [Related]
7. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.
Furukawa T; Sunamura M; Motoi F; Matsuno S; Horii A
Am J Pathol; 2003 Jun; 162(6):1807-15. PubMed ID: 12759238
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
9. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T
Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806
[TBL] [Abstract][Full Text] [Related]
10. An extracellular ligand increases the specific activity of the receptor-like protein tyrosine phosphatase DEP-1.
Sörby M; Sandström J; Ostman A
Oncogene; 2001 Aug; 20(37):5219-24. PubMed ID: 11526512
[TBL] [Abstract][Full Text] [Related]
11. RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo.
Ulbricht U; Eckerich C; Fillbrandt R; Westphal M; Lamszus K
J Neurochem; 2006 Sep; 98(5):1497-506. PubMed ID: 16923162
[TBL] [Abstract][Full Text] [Related]
12. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
13. HD-PTP: A novel protein tyrosine phosphatase gene on human chromosome 3p21.3.
Toyooka S; Ouchida M; Jitsumori Y; Tsukuda K; Sakai A; Nakamura A; Shimizu N; Shimizu K
Biochem Biophys Res Commun; 2000 Nov; 278(3):671-8. PubMed ID: 11095967
[TBL] [Abstract][Full Text] [Related]
14. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant adenovirus vector mediated human interleukin-24 gene transfection on pancreatic carcinoma growth.
Pan XT; Zhu QY; Li DC; Yang JC; Zhang ZX; Zhu XG; Zhao H
Chin Med J (Engl); 2008 Oct; 121(20):2031-6. PubMed ID: 19080270
[TBL] [Abstract][Full Text] [Related]
16. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model.
Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378
[TBL] [Abstract][Full Text] [Related]
17. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation].
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Villa V; Pattarozzi A; Diana F; Fusco A; Schettini G
Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma.
Cheung AK; Lung HL; Hung SC; Law EW; Cheng Y; Yau WL; Bangarusamy DK; Miller LD; Liu ET; Shao JY; Kou CW; Chua D; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
Cancer Res; 2008 Oct; 68(19):8137-45. PubMed ID: 18829573
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptor.
Bernard-Pierrot I; Ricol D; Cassidy A; Graham A; Elvin P; Caillault A; Lair S; Broët P; Thiery JP; Radvanyi F
Oncogene; 2004 Dec; 23(57):9201-11. PubMed ID: 15516981
[TBL] [Abstract][Full Text] [Related]
20. Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathway.
Finch JS; Tome ME; Kwei KA; Bowden GT
Free Radic Biol Med; 2006 Mar; 40(5):863-75. PubMed ID: 16520238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
